GAM Holding’s NeoGenomics NEO Stock Holding History

GAM Holding’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,689	Closed	-$87K	–	254
2022 Q2	$87K	Hold	10,689	–	–	0.01%	250
2022 Q1	$130K	Sell	10,689 -6,220	-37%	-$131K	0.01%	308
2021 Q4	$577K	Hold	16,909	–	–	0.03%	231
2021 Q3	$816K	Sell	16,909 -13,685	-45%	-$634K	0.04%	210
2021 Q2	$1.38M	Sell	30,594 -4,476	-13%	-$198K	0.06%	210
2021 Q1	$1.69M	Buy	+35,070	New	+$1.83M	0.08%	209
2020 Q4	–	Sell	-158,104	Closed	-$5.83M	–	310
2020 Q3	$5.83M	Buy	158,104 +24,300	+18%	+$903K	0.35%	91
2020 Q2	$4.14M	Sell	133,804 -24,800	-16%	-$687K	0.26%	115
2020 Q1	$4.38M	Hold	158,604	–	–	0.3%	98
2019 Q4	$4.64M	Hold	158,604	–	–	0.22%	139
2019 Q3	$3.03M	Hold	158,604	–	–	0.13%	176
2019 Q2	$3.48M	Hold	158,604	–	–	0.14%	171
2019 Q1	$3.25M	Buy	+158,604	New	+$2.76M	0.14%	177

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GAM Holding's NEO Position: Q3 2022 in Review

GAM Holding sold out of NeoGenomics (NEO) in Q3 2022, closing a stake of 10,689 shares — an estimated $87K sold.

GAM Holding first reported a position in NEO in Q1 2019 and held it in 13 quarters. The position peaked at $5.83M in Q3 2020. 245 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

GAM Holding reported no remaining NeoGenomics position as of Q3 2022 after selling out during the quarter.
GAM Holding sold 10,689 NeoGenomics shares in Q3 2022, an estimated $87K.
GAM Holding first reported a position in NeoGenomics in Q1 2019 and held it in 13 quarters.
GAM Holding's NeoGenomics position peaked at $5.83M in Q3 2020.
245 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on GAM Holding's 13F filing for Q3 2022, filed 19 Oct 2022.